High-throughput screening (HTS) is an established technology in the pharmaceutical industry (1). Over the past decade, there has been a logarithmic increase in the industry's ability to screen large combinatorial libraries of compounds against target molecules (2). The technology to achieve this has come in the form of robotics, high-density microplates, small volume (microliter) liquid handling, and sophisticated detection schemes. Signifi cant effort has gone into the design of HTS workstations capable of screening tens of thousands of compounds in a 24-h period. However, these workstations come with a large price tag, ranging from several hundred thousand to millions of dollars. A considerable amount of work is necessary to optimize nascent microfl uidic devices for HTS applications. Stateof-the-art commercial microfl uidic devices are principally made by the micromachining of silicon (3) and glass and rely on electroosmotic fl ow (4,5) to drive liquid through the channels, requiring high salt concentrations and a voltage source. This process generates gas bubbles, creating ionic conditions that are far from ideal for assays measuring enzymatic activity or protein-protein interactions. Other problems with hard polymer microfl uidic devices include the need to build up layers to effi ciently seal the channel networks, making layer-layer adhesion a serious concern during the fabrication process, and the lack of a good compartmentalization technology for the large-scale analysis of chemical or biological libraries. In thinking about a generic design for microfl uidic HTS devices for catalytic screening applications that confi ne both enzyme and substrate to picoliter volumes, both serial and parallel approaches can be explored. Using a serial strategy, each compound of interest is screened sequentially using a common microfl uidic channel with a single detection element. Mechanically, throughput depends on factors such as fl ow speed, sample concentration, and the acquisition time of the detector. In contrast, parallel screening functions like an ultra-high density microplate, in which thousands of compounds are arrayed into individual picoliter-scale compartments, with a detector element that probes the entire matrix. Throughput is principally limited by the number of compartments in the array. We have designed and developed microfl uidic chips employing both serial and parallel screening strategies. Unlike in state-ofthe-art microfl uidic devices relying on electroosmotic fl ow, fl uidic traffi cking and compartmentalization in our chips are pressure-based, using integrated elastomeric valves whose function is independent of solvent composition.
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Droplet-Generating Microfluidic Devices for Soluble Assays
Encapsulation of biological agents is not a new concept for the pharmaceutical industry. For the past two decades, liposomes have been used as carriers for a wide variety of drugs, including anti-tumor and anti-fungal compounds, as well as genetic drugs, such as antisense oligonucleotides and plasmids for gene therapy (6) . However, liposomes are diffi cult to prepare, requiring organic solvents to hydrate the dried lipid mixture and techniques, such as sonication or French press, to size the fi nal liposomes. Problems with the fi nal product include size heterogeneity and poor aqueous encapsulation rates, often as low as 20% (7). Emulsions, consisting of water, oil, and a surfactant, are an alternative to liposomes. Depending on the relative concentration of each component, emulsions can exist as micelles consisting of surfactant-stabilized oil droplets in an aqueous solution or as reverse micelles in which water droplets are present in a bulk oil solution. While reverse micelles have the advantage over liposomes of encapsulating 100% of the aqueous phase, synthesis of homogeneous emulsions has been considered a black art (8) .
Recognizing their potential as miniature bioreactors, we have developed microfl uidic devices capable of producing highly homogeneous emulsions. In recent work, we introduced a new emulsifi cation technology utilizing elastomer-based microfl uidic devices (9) . The microfl uidic devices, consisting of optically transparent polydimethylsiloxane (PDMS), are cast from silicon wafer molds containing positive-relief channels by using standard lithographic techniques. Within these devices, pressurized immiscible fl uids are mixed at an orthogonal junction of two microchannels, combining cross-fl ow and viscous shear to generate monodisperse water-in-oil (W/O) droplets with picoliter-scale volumes [coeffi cient of variation (CV) < 5%] (Figure 1 ). The addition of nonionic surfactants adds stability to the formed droplets. By modifying the relative pressures of the two fl uids, the size of the formed droplets can range from nanometers to microns in diameter. Capable of generating thousands of droplets per second, these devices are being optimized for high-throughput enzymatic screening assays, dynamically encapsulating single cells expressing recombinant enzyme and substrate in each droplet. Mixing in the droplets confi ned in the microchannels, with typical diameters of 10-20 µm, is highly effi cient. Flow is laminar in the microfl uidic chips, preventing mixing of the aqueous components until after encapsulation. However, after formation, the aqueous droplets suspended in the bulk oil solution contact the top and bottom microchannel walls as they fl ow toward the outlet. In a straight microfl uidic channel, this contact sets up in the droplet a bilateral circulating fl ow fi eld, which resembles two counter-rotating vortices. By introducing bends into the devices, the streamlines in these vortices fold over on each other, resulting in rapid mixing of the droplet contents. Depending on the droplet fl ow rate and the number of bends in the devices, mixing times on the millisecond time scale have been reported for dyes like Fluo-4 (10). With rapid mixing dynamics, these devices have potential applications not only in end point assays but also for real-time monitoring of enzyme kinetics at the single-cell level.
poised to fi ll this role, using ultra-low sample volumes and multiplexing technology to provide high-density, addressable screening platforms for both in vitro and cell-based applications. As we perfect the manufacture procedure for these devices, the future challenges lie in adapting biological protocols for nanoliter-scale assays. For applications like single-cell enzymatic assays, expression variability, which is dependent on factors like the stage of a cell in its growth cycle and the diffi culty of expressing the protein of interest, must be taken into consideration. This additional noise, which is averaged out in microplate-based assays that measure the average activity of group of cells, makes selection of mutants with small improvements in activity more diffi cult to identify. However, high-throughput-based microfl uidic devices, which can rapidly screen thousands of cells in either a serial or parallel format, may be able to identify "super" mutants 
Addressable Microfluidic Array Devices
Primarily for HTS applications, clever array-based micropatterning and compartmentalization systems for cells and proteins have been established by a variety of techniques. Examples include polydimethylsiloxane (PDMS) membranes with molded pores for the deposition of cell and protein arrays onto glass substrates (11, 12) , the patterning of biomolecules using elastomeric stamps (13, 14) , and nanoliter-scale assay plates (15) . We have used multilayer soft lithography (16) to make array-based microfl uidic devices with thousands of individually addressable chambers (Figure 2 ). Microchannels on the bottom of the devices, when sealed to a glass coverslip, serve as conduits for biological material whose fl ow is regulated by integrated elastomeric valves. The devices are initially fabricated as two distinct silicone layers on microchannel-patterned silicon wafers. The thick silicone layer containing the channels required to actuate the valves (control channels) is covalently bonded to a thin layer of silicone containing the channels that will be fi lled with biological reagents (fl ow channels), such that a silicone membrane with a thickness of approximately 30 µm separates the control and fl ow channels at the points where they overlap. The membrane in the crossover regions functions as a valve, in which pneumatic pressure applied to the control channels causes the elastomeric membrane to defl ect down, closing off the underlying fl ow channels (Figure 3 ). Pneumatic actuation of the valves is accomplished through interconnect holes punched through the thick layer prior to the secondary bonding step, connecting the isolated control channels to a pressurized air supply controlled by miniature solenoid valves, while interconnect holes on the bottom fl ow layer provide access for sample input and output. Specifi c actuation of these valve arrays using computer software creates an elaborate fl uidic traffi cking system, in which individual cells can be independently compartmentalized, assayed, and recovered from the devices (17) .
Future Applications and Challenges
Increasing biocomplexity created by explosive advances in genomics and proteomics in the last decade has established the need for HTS technologies to transform the vast collections of data generated from these systems into organized knowledge (18) . Elastomeric microfl uidic chips are in a recombinant protein library (10 5 -10 7 ) that may never be found by techniques that only sample a small fraction of the library diversity. Without the need to isolate, grow, and induce cells in individual wells of microplates, integrated microfl uidic devices can reduce the screening process from days to hours, depending on the assay parameters. While much of the research is still at the proof-of-concept stage, microfl uidics has the potential to transform biochemical analysis in the same way that miniaturization transformed computing, making tools that are smaller, more integrated, less expensive, and a lot faster (19) .
